Home Reported Outcomes in C3G Study

Clinical trial NCT07029542 · RECRUITING

Trial details

NCT number: NCT07029542
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

C3 Glomerulopathy

Start date: 2025-04-07
Primary completion: 2026-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.